ASTRAZENECA PLC - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for Conduit Pharmaceuticals Inc. (CDT)

Filing Manager: ASTRAZENECA PLC
Reporting Manager: AstraZeneca PLC
Security: Conduit Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Symbol: CDT
Shares outstanding: 6.72M shares
Disclosed Ownership: 73.9K shares
Ownership: 1.1%
Form type: SCHEDULE 13G/A
Date filed: 4/10/2025, 06:00 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
AstraZeneca PLC	1.1%	73.9K	73.9K	0	/s/ Adrian Kemp	Adrian Kemp, Company Secretary
AstraZeneca AB	1.1%	73.9K	73.9K	0	/s/ Lars-Johan Cederbrant	Lars-Johan Cederbrant, Director and CFO